Lorcaserin treatment decreases body weight and improves cardiometabolic risk factors of obese adults: A 6-month-long, randomized, placebo-controlled, double-blind clinical trial
Diabetes, Obesity and Metabolism | Mar 20, 2019
Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial
Diabetes, Obesity and Metabolism | Mar 20, 2019
Efficacy and safety of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase 3, open-label, 2:1 randomized, treat-to-target trial
Diabetes, Obesity and Metabolism | Mar 20, 2019
Effects of lixisenatide on postprandial blood pressure, gastric emptying, and glycemia in healthy people and people with type 2 diabetes
Diabetes, Obesity and Metabolism | Mar 20, 2019
Metformin attenuates the postprandial fall in blood pressure in type 2 diabetes
Diabetes, Obesity and Metabolism | Mar 20, 2019
Effects of colchicine in adults with metabolic syndrome: A pilot randomized controlled trial
Diabetes, Obesity and Metabolism | Mar 20, 2019
Glycemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting
Diabetes, Obesity and Metabolism | Mar 20, 2019
Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin
Diabetes, Obesity and Metabolism | Mar 20, 2019
A variety of information related to Medicine and Health Care. It's all here.
